Galapagos NV announced the appointment of Aaron Cox as Chief Financial Officer, effective July 7, 2025. Aaron Cox, who previously served as Executive Vice President and CFO at Horizon Therapeutics, will succeed Thad Huston. Cox will oversee Finance, Accounting, Tax, Procurement, Communications, and Investor Relations, and will join the Executive Committee. He will also collaborate with leadership and the Board to drive business development and pipeline growth.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Galapagos NV published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001171843-25-004083), on June 25, 2025, and is solely responsible for the information contained therein.